Clinical significance and prognostic value of PAX3 expression in human glioma

Journal of Molecular Neuroscience

Volumn 47, Issue 1, 2012, Pages 52-58

  Chen, Jian ^a   Xia, Liang ^a   Wu, Xiujie ^a   Xu, Liqin ^a   Nie, Dekang ^a   Shi, Jinlong ^a   Xu, Xide ^a   Ni, Lanchun ^a   Ju, Shaoqing ^a   Wu, Xinhua ^a   Zhu, Hui ^a   Shi, Wei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Clinical significance; Expression; Glioma; PAX3; Prognostic value

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR PAX3;

ARTICLE; BRAIN TISSUE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EPILEPSY; FEMALE; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MIDDLE AGED; PAIRED BOX TRANSCRIPTION FACTORS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84859732476     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9677-1     Document Type: Article

References (29)

1. Barr FG, Fitzgerald JC, Ginsberg JP, Vanella ML, Davis RJ, Bennicelli JL (1999) Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res 59:5443-5448 (Pubitemid 29526453)
2. Blake JA, Thomas M, Thompson JA, White R, Ziman M (2008) Perplexing Pax: from puzzle to paradigm. Dev Dyn 237:2791-2803
3. Brandes AA (2003) State-of-the-art treatment of high-grade brain tumors. Semin Oncol 30:4-9
4. Chi N, Epstein JA (2002) Getting your Pax straight: Pax proteins in development and disease. Trends Genet 18:41-47 (Pubitemid 34031857)
5. Frascella E, Toffolatti L, Rosolen A (1998) Normal and rearranged PAX3 expression in human rhabdomyosarcoma. Cancer Genet Cytogenet 102:104-109 (Pubitemid 28164925)
6. Frigerio G, Burri M, Bopp D, Baumgartner S, Noll M (1986) Structure of the segmentation gene paired and the Drosophila PRD gene set as part of a gene network. Cell 47:735-746 (Pubitemid 17011417)
7. Frost V, Grocott T, Eccles MR, Chantry A (2008) Self-regulated Pax gene expression and modulation by the TGFbeta superfamily. Crit Rev Biochem Mol Biol 43:371-391
8. Fukuda ME, Iwadate Y, Machida T, Hiwasa T, Nimura Y, Nagai Y, Takiguchi M, Tanzawa H, Yamaura A, Seki N (2005) Cathepsin D is a potential serum marker for poor prognosis in glioma patients. Cancer Res 65:5190-5194 (Pubitemid 40827328)
9. Godbout R, Bisgrove DA, Shkolny D, Day RS 3rd (1998) Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 16:1955-1962 (Pubitemid 28200607)
10. Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr, Gillespie GY (2008) CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3:e3655
11. Jemal A,Murray T,Ward E, Samuels A, Tiwari RC,Ghafoor A, Feuer EJ, ThunMJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30 (Pubitemid 40310185)
12. Jiang L, Mao P, Song L, Wu J, Huang J, Lin C, Yuan J, Qu L, Cheng SY, Li J (2010) miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177:29-38
13. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-25, discussion 226-9
14. Kozmik Z (2008) The role of Pax genes in eye evolution. Brain Res Bull 75:335-339
15. Lang D, Lu MM, Huang L, Engleka KA, Zhang M, Chu EY, Lipner S, Skoultchi A, Millar SE, Epstein JA (2005) Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433:884-887 (Pubitemid 40314899)
16. Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA (2007) PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol 73:1-14 (Pubitemid 44868976)
17. Liu Y, Zhu H, Liu M, Du J, Qian Y, Wang Y, Ding F, Gu X (2011) Downregulation of Pax3 expression correlates with acquired GFAP expression during NSC differentiation towards astrocytes. FEBS Lett 585:1014-1020
18. Mansouri A, Hallonet M, Gruss P (1996) Pax genes and their roles in cell differentiation and development. Curr Opin Cell Biol 8:851-857 (Pubitemid 26399946)
19. Medic S, Ziman M (2009) PAX3 across the spectrum: from melanoblast to melanoma. Crit Rev Biochem Mol Biol 44:85-97
20. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR (2003) Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22:7989-7997 (Pubitemid 37179944)
21. Noll M (1993) Evolution and role of Pax genes. Curr Opin Genet Dev 3:595-605
22. Parker CJ, Shawcross SG, Li H, Wang QY, Herrington CS, Kumar S, MacKie RM, Prime W, Rennie IG, Sisley K, Kumar P (2004) Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin. Int J Cancer 108:314-320 (Pubitemid 37541789)
23. Plummer RS, Shea CR, Nelson M, Powell SK, Freeman DM, Dan CP, Lang D (2008) PAX3 expression in primary melanomas and nevi. Mod Pathol 21:525-530 (Pubitemid 351589648)
24. Rajan P, Panchision DM, Newell LF, McKay RD (2003) BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 161:911-921 (Pubitemid 36718424)
25. Robson EJ, He SJ, Eccles MR (2006) A PANorama of PAX genes in cancer and development. Nat Rev Cancer 6:52-62 (Pubitemid 43053651)
26. Scholl FA, Kamarashev J, Murmann OV, Geertsen R, Dummer R, Schafer BW (2001) PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res 61:823-826 (Pubitemid 32174385)
27. Schulte TW, Toretsky JA, Ress E, Helman L, Neckers LM (1997) Expression of PAX3 in Ewing's sarcoma family of tumors. Biochem Mol Med 60:121-126 (Pubitemid 27198134)
28. Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR (1998) Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40:151-160 (Pubitemid 29010168)
29. Wu M, Li J, Engleka KA, Zhou B, Lu MM, Plotkin JB, Epstein JA (2008) Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice. J Clin Invest 118:2076-2087 (Pubitemid 351872327)